EDIT vs MPC · rev $32.3M vs P/E 16, rev $138.86B
Editas Medicine Inc (EDIT) versus Marathon Petroleum Corp (MPC) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Marathon Petroleum Corp (MPC) is a oil & gas refining & marketing company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported MPC revenue for 2024-12-31 was $138.86B. Net income was $5.07B. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MPC currently screens at market cap $71.41B and trailing P/E 16.1.
EDIT currently screens at market cap $375.2M. MPC currently screens at market cap $71.41B and trailing P/E 16.1.
Not investment advice. Open the EDIT and MPC stock pages for the full models.
Not investment advice.